Elan Drug Technologies

Elan Drug Technologies (EDT) is the world’s leading drug delivery company and is a business unit of Elan (NYSE:ELN).

As a fully integrated drug delivery business, we deliver clinically meaningful benefits to patients, by using our extensive experience and proprietary delivery technologies in partnership with pharmaceutical companies to develop new and innovative products.

Established 40 years ago, we have been applying our skills and knowledge from product concept development, right through to full scale commercial manufacturing. We have been, and continue to be, the drug delivery company of choice for many of the world’s largest pharmaceutical companies. We offer our clients unrivalled drug delivery expertise with a suite of commercially launched, proprietary, technology-driven solutions. From NanoCrystal® technology for poorly water soluble compounds, to customised oral drug technologies, we have a strong track record of innovation and experience.  Our manufacturing and development facilities are based in the United States and Europe. Today, products enabled by our technologies are used worldwide by millions of patients each day.


Elan Drug Technologies – Business Summary

World’s leading drug delivery service provider

• 40 years of innovation and expertise in drug delivery
• Successful collaborations with majority of world’s leading pharma companies
• Most successful drug delivery company in US in recent times – 11 products launched since 2001

Unrivalled expertise in drug formulation, development, scale-up & manufacture

• More than 30 products launched in 100+ countries
• 14 products in clinical development
• Extensive product development, scale-up and manufacturing capabilities in US and EU

Most robust drug delivery technology portfolio in the industry

• NanoCrystal® Technology– 5 products launched with over $1.8B annual in-market sales
• Oral Controlled Release Platform – delayed release, extended release, pulsatile release, chrono-timed delivery; all commercially launched
• 1,900+ patents/patent applications around our technologies

Elan Drug Technologies - Strength in Numbers

• 3 million patients benefit from drugs incorporating our technologies
• 40 years in drug delivery business
• 35 products marketed in 100+ countries
• 1,900+ patents/patent applications world-wide
• 10 validated technologies
• 14 products in clinical development
• 250,000 sq ft dedicated GMP manufacturing facilities
• 3 billion solid oral dosages can be manufactured annually
• Over $15 billion in market sales generated for our licensees